Well, you deserve these gains, buying and holding before FDA approval is not for the faint of heart. Good luck to you.
On the flip side, for those of us "late" to the party, in terms of "risk vs reward", this is the sweet spot. De-risked but not yet generating significant revenue. When it comes, and now we know IT WILL, this will re-rate by multiples.
This has an amazing product, meeting extremely serious medical needs, with multi- billion dollar markets, and large sales on the cusp of being realised. That's not overvalued. Overvalued is a stranded lithium deposit in some African hell hole, far away from infrastructure.
Well, you deserve these gains, buying and holding before FDA...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.97 |
Change
-0.080(2.62%) |
Mkt cap ! $202.2M | |||
| Open | High | Low | Value | Volume |
| $3.03 | $3.03 | $2.96 | $304.6K | 102.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $2.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.00 | 124952 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |